George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
achilles
Apologies..I thought you were talking about 2 separate things ....my mistake
I didnt even comment on the phase 3 trial---blimey...where to begin ...so i went for the easier first part of your comment ..lol
" US based clinical sites will be added to the global clinical trial program for CimetrA® in order to initiate the registration process for CimetrA® in the US "
so...it seems the FDA needs US patients ..in order to obtain any future FDA approval licence
...so now... maybe the change in focus has been to move from Brazil and Brazilian patients to the US ..and American patients ...due to the FDA requirements
...and hence the number of patients who have done their trial isn't there yet ..because they now are involving the US... but...it isn't clear how many US patients or even who is paying for those US patients in the trial....I seem to remember them saying that AMC will "initiate" those patient trials....but I don't know who is paying for them,in the US ...AMC or MXC ??
I guess the quarter update if next week may have some detail/update on it ....but ... they clearly have dropped all mention of Brazil...they now only talk about Israel....and of course ... using patients in the US via AMC
Israel of course has had issues with further outbreaks of COVID over the summer ..despite high vaccine uptake..and have been giving the boosters ...
Yey!
Good to see you back Pokerchips :-)
I was talking about the phase 3 trial results
Hi Pokerchips,
Are you talking about Cimetra trials? There were no results listed in the 01 september RNS and as stated in their July 12th RNS when the trials commenced "The trial is expected to commence in the coming week and conclude around September 2021 with results then available in October 2021".
Feel free to correct me /update me if im wrong.
" The full results are due this month and we haven't even had the interim yet! "
achilles,
The full (prelim) results came out in an RNS dated 01st September for the Financial Year End June 30th 2021
The next Quarterly update is due maybe next week which is for Q1 of the new Financial Year FY22
The Interims come out in February
#Jackdaw
Then why are you still here and holding?
It doesn't make sense!
If its not worth holding then sell simples!
Shares go up and down, there is more than one player in this market and Covid hasn't gone away.
Hold for Gold, bail at a loss.
The choice is yours...
Looks to me that its time to dump this load of kaka and take a loss. The Merck pill beat us to the finishing line. IMO not even worth a hold.
The full results are due this month and we haven't even had the interim yet! No updates about the trial for 4 months, what have they been doing??
Should have been. But at the rate they were recruiting patients, as of July, less than 1% of participants, I woiuldn't hold my breath.
I thought the trial results were due out this month?
Mornington, is a big shame, but their trail wont finish until around march nxt year, by then its all over, Merck have ruled. Prove us wrong mgc :) dare ya!!!
Shame the government haven’t given MXC a contract to supply CimetrA
Yup, shud of been mgc if they didnt sit on it and twiddled thumbs. Hey ho......
If only